Corebridge Financial (CRBG), the insurance and retirement services arm spun off from AIG in September 2022, has been riding a wave of post-separation optimism that feels increasingly detached from its operational realities. While analysts paint a rosy picture with price targets implying roughly 6% to 35% upside from recent levels, the data screams caution: plummeting profitability in the near term, a major shareholder aggressively dumping stock, and fundamentals that reveal a company still shedding the baggage of its AIG parentage amid volatile interest rates and a softening insurance market. This isn’t the story of a lean spin-off powerhouse; it’s a reminder that one-off separation gains masked deeper structural weaknesses, and consensus may be overlooking the risks of renewed losses and stagnant growth.
Revenue Trends and Operational Efficiency: A Post-Peak Plateau
Revenue tells a tale of boom-and-bust tied directly to the spin-off. From $15.1 billion in 2020, it surged 54% to $23.3 billion in 2021 and another 6% to $25 billion in 2022—likely fueled by AIG portfolio reallocations and favorable market conditions during the spin-off hype. But reality bit hard post-2022: a 24% plunge to $18.8 billion in 2023, stabilizing at $18.7 billion in 2024 and dipping slightly 1% to $18.5 billion in 2025 projections. Analysts forecast a rebound, with 15% growth to $21.3 billion in 2026, then 5% annually to $23.3 billion by 2028. This projected acceleration assumes rising rates boost annuity sales, but skeptically, it ignores the insurance sector’s sensitivity to economic slowdowns—recall how 2022’s rate hikes initially juiced revenues but exposed reserve strains.
Per-employee revenue underscores efficiency gains, rocketing from $2.7 million in 2021 to $3.6 million in 2024 and $3.9 million in 2025—a 38% improvement over four years—as headcount slashed from 8,500 to 4,800 (a 44% cut). This leaner operation is crucial for margins in a capital-intensive industry, yet gross margins collapsed from 58% in 2022 to 24% in 2025, signaling cost pressures or pricing competition eroding the benefits. Correlation here is stark: revenue growth decoupled from profitability post-spin-off, hinting at unsustainable expense bloat.
Profitability Swings: From Spin-Off Windfalls to 2025 Losses
Earnings paint the most contrarian picture. Net income exploded to $9.2 billion in 2021 and $8.5 billion in 2022 (a staggering 670% jump from 2020’s $866 million), almost certainly from one-time AIG separation gains and investment income amid surging bond yields. But normalized, it cratered 88% to $1.0 billion in 2023, rebounded 113% to $2.2 billion in 2024, only for projections to show a 118% drop to a $390 million loss in 2025. Analysts expect a sharp V-shaped recovery to $2.4 billion in 2026 (515% turnaround), stabilizing around $2.5 billion thereafter. EBT margins echo this volatility: 48% in 2021 to a dismal -2.9% in 2025.
ROE, a key gauge of shareholder value creation, followed suit—peaking at 42% in 2022 before sliding to -2.8% in 2025 projections. This isn’t just cyclical; it’s a red flag for insurance firms where ROE above 15% signals competitive moats. Book value per share offers solace, climbing from $20.61 in 2024 to $25.89 in 2025 (26% gain) and $31.70 in 2026, supported by shrinking shares outstanding—from 598 million in 2024 to 482 million by 2026 (20% reduction via buybacks?). Yet, with shares down amid insider sales, this “growth” may reflect dilution avoidance rather than organic strength.
Cash Flow and Balance Sheet: Solid but Debt-Laden
Free cash flow per share held resilient at $3.60-$5.22 from 2018-2023 before easing to $3.75 in 2025, mirroring operating cash flows that peaked at $3.4 billion in 2023 but halved to $2.0 billion in 2025. Crucially, capex remains negligible (zero per share), a boon for insurers focused on investments over physical assets—EV/FCF ratios thus stay reasonable at 13x recently, cheaper than peers in a high-rate world. However, the balance sheet looms large: working capital deeply negative at -$259 billion in 2025 (typical for insurers holding policy liabilities), total debt at $10.9 billion (down 12% from 2024), and net debt $10.5 billion. ROIC dipped to 0.03% in 2025 from 8.8% prior, highlighting inefficient capital deployment amid AIG’s legacy overhang.
Valuation Metrics: Cheap, But for Good Reason?
Multiples scream value—or value trap. Trailing PE ballooned to 17.9x in 2025 amid losses, but forward projections drop to 6x by 2026, with PS ratios under 1x and PB at 1.2x. Historical PS hovered 0.5-1.0x post-2022, while EV/Sales projects to 0.6x by 2028—undervalued if growth materializes, but consensus ignores execution risks. Stock price evolution correlates tightly with these swings: 2022 range $19-$24 amid spin-off buzz, crashed to $14-$22 in 2023 as gains faded, recovered to $22-$35 in 2024 on rate tailwinds, and $24-$37 in 2025. Recent levels sit midway in that band, decoupling from the 2025 loss outlook—perhaps markets front-run the rebound, but that’s optimistic.
Insider Activity: A 10% Owner’s Fire Sale Signals Doubt
Zero buys across 2025-2026, but sells totaling over $3.2 billion—dominated by a single 10% owner (likely AIG divesting its stake). This entity offloaded 133 million shares in May 2025 at around recent levels (reducing holdings to 114 million), 30 million in August (to 84 million, 26% cut), 1.2 million in September, 33 million in November (to 50 million, 40% further drop), and 25 million in February 2026 (to 25 million). These timed sales at $30-$34/share coincide with price peaks, slashing ownership from over 100%? Wait, totals suggest rapid de-risking post-spin-off lockups. Insiders don’t sell like this lightly; it correlates with the 2025 loss projection and flat revenues, challenging bullish narratives. AIG’s full exit could pressure supply, especially with 20% share shrinkage elsewhere.
Historical Context: AIG Spin-Off Legacy and Macro Risks
CRBG’s arc ties to AIG’s 2008 crisis redemption—bailed out for $182 billion, AIG spun off units like Corebridge to streamline. The 2022 IPO valued it at $17 billion, but performance lagged: stock halved from spin highs by 2023 lows amid rate normalization hurting annuities. Recent decade’s low rates crushed insurers (pre-2022), but hikes since then aided investments—yet Fed pauses and potential cuts in 2026 could reverse that. Competitors like Athene or Apollo thrive on scale; CRBG’s employee cuts help, but revenue/emp plateaus question differentiation.
Analyst Projections vs. Contrarian Risks: Upside Capped?
Analysts’ mean target suggests 19% potential gain, high-end 35%, low 6%—tied to revenue ramp and EPS climbing from implied 2025 negativity to $6.45 by 2028 (73% growth). Earnings per share projections: $5.21 (2026), $5.95 (2027), $6.45 (2028), with revenue/share up 41% to $48.39. If realized, PE compresses to 4.8x, a steal. But contrarily: 2025’s loss (EBT negative) amid insider exodus hints at underwriting missteps or investment hits. Debt at 11x EBITDA-equivalent risks refinancing in a downturn; ROA/ROE negativity forecasts inefficiency. Sector tailwinds (rates) fade, competition intensifies, and no buys signal internal skepticism.
In sum, CRBG trades like a turnaround gem, but data correlations—revenue stall, profit volatility, insider flood—point to overhyped recovery. Consensus chases 15-20% growth; I’d bet on single digits, with downside if rates fall. At current multiples, it’s a hold for yield hunters, but contrarians should watch AIG’s final stake dump for the real exit signal. Risks outweigh rewards until proven otherwise.
(Word count: 1,128)